Trial Profile
Phase III trial of cabozantinib in metastatic castration-resistant prostate cancer
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2011
Price :
$35
*
At a glance
- Drugs Cabozantinib (Primary)
- Indications Prostate cancer
- Focus Registrational; Therapeutic Use
- 31 Oct 2011 Planned initiation date changed from 1 Jan 2012 to 30 Jun 2012.
- 07 Jul 2011 New trial record